LOGO
LOGO

Olema Pharmaceuticals, Inc. (OLMA)

  • Olema Oncology Announces Encouraging Phase 1 OP-3136 Data In Solid Tumors And ER+/HER2- Metastatic Breast Cancer 5/21/2026 10:04:16 PM
  • Olema Reports Preliminary Phase 1 OP-3136 Data And Phase 3 OPERA-02 Trial Update At ASCO 2026 5/21/2026 9:56:39 PM
  • Olema Pharmaceuticals Q4 Net Loss/shr $0.50 Vs. Loss/shr $0.51 Last Year 3/16/2026 7:13:47 AM
  • Older Articles
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap